Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | LLY | JNJ | ABBV | MRK |
| Company | Novo Nordisk A/S ADR | Eli Lilly and Company | Johnson & Johnson | Abbvie Inc | Merck & Company |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 107.15 | 803.50 | 157.00 | 201.15 | 101.48 |
| High | 107.87 | 847.27 | 157.00 | 201.89 | 103.23 |
| Low | 106.43 | 801.26 | 155.41 | 199.48 | 101.00 |
| Last | 107.20 | 831.54 | 155.47 | 199.50 | 102.92 |
| Change | -0.43 | +34.09 | -1.26 | -1.01 | +1.75 |
| % Change | -0.40% | +4.27% | -0.80% | -0.50% | +1.73% |
| Volume | 4,964,262 | 6,718,566 | 8,442,621 | 4,496,505 | 9,143,212 |
| 20-Day Average Volume | 5,570,813 | 4,108,803 | 6,501,271 | 5,480,035 | 9,714,501 |
| Previous Close | 107.63 | 797.45 | 156.73 | 200.51 | 101.17 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 113.51 | 870.46 | 161.26 | 194.37 | 105.23 |
| 20-Day Raw Stochastic | 14.05% | 37.74% | 0.53% | 63.51% | 33.28% |
| 20-Day Relative Strength | 32.07% | 41.37% | 36.00% | 57.30% | 35.86% |
| Weighted Alpha | -6.27 | +29.07 | +3.32 | +40.67 | -8.73 |
| Today's Opinion | 88% Sell | 8% Sell | 8% Buy | 88% Buy | 100% Sell |
| Previous Opinion | 88% Sell | 24% Sell | 24% Buy | 88% Buy | 100% Sell |
| Last Month's Opinion | 72% Sell | 88% Buy | 40% Buy | 96% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.23% since 11/01/24 | +1.54% since 11/01/24 | -2.91% since 11/01/24 | -1.99% since 11/01/24 | +1.02% since 11/01/24 |
| Low | 105.03 on 11/06/24 | 767.61 on 11/06/24 | 155.41 on 11/08/24 | 198.35 on 11/05/24 | 100.52 on 11/05/24 |
| High | 110.66 on 11/04/24 | 847.27 on 11/08/24 | 160.85 on 11/06/24 | 206.15 on 11/06/24 | 103.23 on 11/08/24 |
| 1-Month | |||||
| %Chg | -8.53% since 10/08/24 | -8.99% since 10/08/24 | -2.64% since 10/08/24 | +3.36% since 10/08/24 | -5.16% since 10/08/24 |
| Low | 105.03 on 11/06/24 | 767.61 on 11/06/24 | 155.41 on 11/08/24 | 185.89 on 10/21/24 | 98.60 on 10/31/24 |
| High | 120.56 on 10/11/24 | 937.00 on 10/14/24 | 166.75 on 10/15/24 | 207.32 on 10/31/24 | 111.58 on 10/15/24 |
| 3-Month | |||||
| %Chg | -16.36% since 08/08/24 | -1.63% since 08/08/24 | -2.96% since 08/08/24 | +4.78% since 08/08/24 | -9.66% since 08/08/24 |
| Low | 105.03 on 11/06/24 | 767.61 on 11/06/24 | 155.41 on 11/08/24 | 185.89 on 10/21/24 | 98.60 on 10/31/24 |
| High | 139.74 on 08/30/24 | 972.53 on 08/22/24 | 168.85 on 09/04/24 | 207.32 on 10/31/24 | 120.30 on 09/06/24 |
| 6-Month | |||||
| %Chg | -15.38% since 05/08/24 | +7.30% since 05/08/24 | +4.38% since 05/08/24 | +24.34% since 05/08/24 | -20.56% since 05/08/24 |
| Low | 105.03 on 11/06/24 | 747.55 on 08/05/24 | 143.71 on 05/29/24 | 153.58 on 05/30/24 | 98.60 on 10/31/24 |
| High | 148.15 on 06/25/24 | 972.53 on 08/22/24 | 168.85 on 09/04/24 | 207.32 on 10/31/24 | 134.63 on 06/25/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 482,993,088 | 757,032,000 | 377,346,752 | 354,329,248 | 256,243,968 |
| Shares Outstanding, K | 4,487,532 | 949,316 | 2,407,623 | 1,767,140 | 2,532,806 |
| Annual Sales | 33,724,300,000 | 34,124,100,000 | 85,159,000,000 | 54,318,000,000 | 60,115,000,000 |
| Annual Net Income | 12,150,770,000 | 5,240,400,000 | 35,153,000,000 | 4,863,000,000 | 365,000,000 |
| Last Quarter Sales | 9,821,060,000 | 11,439,100,000 | 22,471,000,000 | 14,460,000,000 | 16,657,000,000 |
| Last Quarter Net Income | 2,893,220,000 | 970,300,000 | 2,694,000,000 | 1,561,000,000 | 3,157,000,000 |
| 60-Month Beta | 0.42 | 0.43 | 0.53 | 0.63 | 0.40 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.65 on 08/07/24 | 1.18 on 10/30/24 | 2.42 on 10/15/24 | 3.00 on 10/30/24 | 1.57 on 10/31/24 |
| Latest Earnings Date | 11/06/24 | 10/30/24 | 10/15/24 | 10/30/24 | 10/31/24 |
| Most Recent Dividend | 0.362 on 08/16/24 | 1.300 on 08/15/24 | 1.240 on 08/27/24 | 1.550 on 10/15/24 | 0.770 on 09/16/24 |
| Next Ex-Dividends Date | 08/16/24 | 11/15/24 | 11/26/24 | 01/15/25 | 09/16/24 |
| Ratios | |||||
| Price/Earnings ttm | 34.10 | 76.34 | 15.42 | 18.72 | 16.93 |